Cellbyte vs OpsLevel

Side-by-side comparison of AI visibility scores, market position, and capabilities

Cellbyte leads in AI visibility (40 vs 24)

Cellbyte

EmergingHealthcare

General

AI pharma drug launch platform compressing market access research from months to minutes; six-figure ARR within weeks of launch with Bayer as client across 12 markets.

AI VisibilityBeta
Overall Score
C40
Category Rank
#1077 of 1158
AI Consensus
79%
Trend
up
Per Platform
ChatGPT
42
Perplexity
36
Gemini
40

About

Cellbyte is an AI-powered pharmaceutical drug launch platform that accelerates global drug launches by providing real-time pricing and market access intelligence — compressing processes that traditionally take months or years (reference pricing analysis, health technology assessment research, payer landscape mapping) into minutes using AI-driven data aggregation and analysis. Founded in 2024 and a Y Combinator graduate, Cellbyte raised $2.75 million in seed funding led by Frontline Ventures and Y Combinator, achieving six-figure ARR within weeks of launch.\n\nCellbyte's platform aggregates regulatory approval data, drug pricing reference lists, payer coverage policies, and health technology assessment outcomes across multiple countries to help pharmaceutical market access teams make faster, better-informed launch sequence decisions. Global drug launches require navigating distinct pricing and reimbursement systems in each country — reference pricing (where one country's price affects another's) makes launch sequencing strategically critical and data-intensive. Cellbyte automates the research that market access consultants previously performed manually.\n\nIn 2025, Cellbyte secured major clients including Bayer across 12 live markets — demonstrating enterprise adoption velocity unusual for a seed-stage company. The pharmaceutical market access software market includes specialized players like IQVIA (market data), ZS Associates (consulting), and early-stage AI entrants. The total addressable market is substantial given the global pharmaceutical market's hundreds of billions in annual drug launches. Cellbyte's 2025-2026 strategy focuses on expanding the breadth of markets covered (targeting all major pharma markets globally), deepening AI capabilities for predictive pricing modeling, and growing its pharmaceutical client base beyond the initial anchor customers.

Full profile

OpsLevel

EmergingDeveloper Tools

Developer Portal

OpsLevel is a developer portal and service catalog for tracking service ownership, maturity scorecards, and production readiness across microservices.

AI VisibilityBeta
Overall Score
D24
Category Rank
#1 of 1
AI Consensus
67%
Trend
up
Per Platform
ChatGPT
22
Perplexity
18
Gemini
26

About

OpsLevel is a developer portal platform that gives engineering organizations visibility into the services they operate, who owns them, and how mature they are relative to internal engineering standards. At its core, OpsLevel maintains a service catalog that maps every microservice, repository, and infrastructure component to a team owner, populating metadata automatically from integrations with GitHub, GitLab, PagerDuty, Datadog, and cloud providers. This catalog becomes the authoritative source of truth for answering questions like who to contact about a service, what tier of reliability it requires, and what dependencies it has — questions that are often unanswerable at engineering organizations that have grown past the point where everyone knows everything.

Full profile

AI Visibility Head-to-Head

40
Overall Score
24
#1077
Category Rank
#1
79
AI Consensus
67
up
Trend
up
42
ChatGPT
22
36
Perplexity
18
40
Gemini
26
45
Claude
32
39
Grok
28

Capabilities & Ecosystem

Capabilities

Only OpsLevel
Developer Portal

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.